Ruxolitinib in Thrombocythemia and Polycythemia Vera

Clinical trial NCT04644211 · RECRUITING

Trial details

NCT number: NCT04644211
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Essential Thrombocythemia Polycythemia Vera

Start date: 2022-03-21
Primary completion: 2027-07-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.